ABOUT
Ibogaine and the Bicameral Mind is a groundbreaking work of literary non-fiction that explores the cultural, scientific, and philosophical dimensions of one of the world’s most enigmatic psychoactive substances.
Drawing on more than fifteen years of research and fieldwork, Jonathan Dickinson weaves together clinical insights, traditional knowledge, and cutting-edge neuroscience to illuminate ibogaine’s unique capacity to transform consciousness.
At once memoir, cultural history, and critical inquiry, the book traces ibogaine’s journey from sacred use in Gabonese initiatory traditions to its contested place in contemporary psychedelic medicine. Dickinson examines the ways ibogaine disrupts addiction, reshapes models of the mind, and challenges prevailing models of trauma and healing, while situating these insights within broader questions of mind, self, and society.
With a rare combination of scholarly rigor and lived experience, Dickinson offers a narrative that is as deeply personal as it is globally relevant. Ibogaine and the Bicameral Mind invites readers to reconsider what it means to heal, to remember, and to imagine the boundaries of human potential.
"From the jungles of Gabon to underground clinics and Navy SEAL recovery programs, this transformative guide reveals ibogaine's potential to bridge spirituality and science, challenging conventional psychiatry and offering hope for those seeking radical healing. A must-read for anyone fascinated by psychedelics, consciousness, and the future of mental health. A must-read for anyone fascinated by psychedelics, consciousness, and the future of mental health."
Normal Ohler
NYT bestselling author of Blitzed, Drugs in Nazi Germany
ABOUT THE AUTHOR
Jonathan Dickinson is the Chief Executive Officer and Co-Founder of Ambio Life Sciences . Recognized internationally as one of the world’s leading experts on ibogaine, Jonathan brings over 15 years of experience in clinical care, traditional practice, and psychedelic research to his leadership at Ambio. A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, he authored the field’s foundational safety guidelines and has published widely on ibogaine’s therapeutic, cultural, and ecological significance.
A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, he authored the field’s foundational safety guidelines and has published widely on ibogaine’s therapeutic, cultural, and ecological significance. In 2018, he secured the first Nagoya-compliant export license for Tabernanthe iboga from Gabon and led the first compliant export. Initiated into the Dissoumba/Fang tradition of Bwiti in 2014 and the Ngondet Missoko tradition in 2022, he brings both scholarly and lived perspectives to his work.
His experience spans multiple worlds, from policy and research to clinical and traditional practice. He has co-authored peer-reviewed studies on ibogaine’s potential in trauma, TBI, pain, MS, and Parkinson’s disease. At Ambio, he leads strategy, research, and innovation — advancing a globally scalable model of care that bridges tradition, science, and integrity.
↠Author of Ibogaine and the Bicameral Mind (2026)
↠CEO to the world's leading ibogaine clinic
↠Contributor to multidisciplinary research
JONATHAN DICKINSON
Stay Connected
Subscribe for updates on events and writing.
Copyright 2026. Jonathan Dickinson